ZEB2 inhibits HBV transcription and replication by targeting its core promoter.
ZEB2 inhibits HBV transcription and replication by targeting its core promoter.
复制标题
DOI:
10.18632/oncotarget.7435
复制
发表时间:
2016-03-29
期刊:
影响因子:
--
通讯作者:
Chen W
中科院分区:
文献类型:
--
作者:
He Q;Li W;Ren J;Huang Y;Huang Y;Hu Q;Chen J;Chen W
Hepatitis B virus (HBV) infection is a major cause of liver diseases, especially liver cirrhosis and hepatocellular carcinoma. However, the interaction between host and HBV has not been fully elucidated. ZEB2 is a Smad-interacting, multi-zinc finger protein that acts as a transcription factor or repressor for several signaling pathways. This study found that the expression of ZEB2 was decreased in HBV-expressing cells. Overexpression of ZEB2 inhibited HBV DNA replicative intermediates, 3.5kb mRNA, core protein level, and the secretion of HBsAg and HBeAg. In contrast, ZEB2 knockdown promoted HBV replication. Furthermore, ZEB2 could bind to HBV core promoter and inhibit its promoter activity. Mutation at the ZEB2 binding site in HBV core promoter eradicated ZEB2-mediated inhibition of HBV replication. This study identifies ZEB2 as a novel host restriction factor that inhibits HBV replication in hepatocytes. These data may shed light on development of new antiviral strategies.